For everyone to have a safe and enjoyable Fourth of July celebration, the American College of…
Category: Primers
Community Healthcare Trust Announces Second Quarter Earnings Release Date And Conference Call
Community Healthcare Trust Incorporated (NYSE: CHCT) today announced that on Tuesday evening, August 3, 2021, after the market closes,…
Children’s Hospital of Philadelphia To Open Pediatric Urgent Care Center in Abington, PA
Children’s Hospital of Philadelphia (CHOP) will open an after-hours Urgent Care Center in Abington, PA dedicated exclusively to children. CHOP also…
Trulieve Expands Access to Medical Cannabis in Central Florida with New Winter Park Location
Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company based…
Cleveland BioLabs, Inc. and Cytocom Announce Registration Statement and Proxy Statement for Previously Announced Merger Declared Effective by SEC
Cleveland BioLabs, Inc. (NASDAQ: CBLI), an innovative biopharmaceutical company developing novel approaches to activate the immune system,…
ExpressionMed CEO & Founder, Thiel Fellow, Meghan Sharkus Celebrates Five Years of Successful Business
ExpressionMed is excited to celebrate five years of providing the diabetes community with fun and creative…
Stay + Namaste At Fairmont Mayakoba In Honor Of International Yoga Day
In celebration of International Yoga Day on June 21, Fairmont Mayakoba is excited to invite guests to “Stay +…
Ending Racism Partnership Panel of Health Experts Addresses Ways to Further Health Equity in Philadelphia and Society
Top regional health experts gathered before a virtual audience of nearly 400 at the “Blueprint to…
C1 Innovation Lab, Blue Cross and Blue Shield of Texas, Enter Collaboration with Capital Factory
The C1 Innovation Lab®, in partnership with Blue Cross and Blue Shield of Texas (BCBSTX), has entered into a collaboration…
Fusion Pharmaceuticals Announces Preliminary Safety and Dosimetry Results from its Single-Dose Portion of the Phase 1 Study of FPI-1434
Product candidate FPI-1434, administered at three different dose levels, demonstrated a favorable safety profile with no…